Diurnal Renames Orphan Drug As Efmody, Expecting EU-Wide Approval
EMA Also OKs Novel Contraceptive With Blockbuster Potential
New treatments for congenital adrenal hyperplasia and relapsing forms of multiple sclerosis are among five drugs recommended for pan-EU approval this month. In addition, harmonized EU advice has been issued for Celltrion’s monoclonal antibody COVID-19 treatment.
